Institutional Manager · CIK 0001757283
ANDERA PARTNERS
PARIS, I0 · File #028-26561
Latest AUM
$176.6M
Positions
5
Top-10 Concentration
100.0%
Filings
1
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | KESTRA MED TECHNOLOGIES LTD | BEKE | +2,540,106 | +$67.4M | $0 |
| NEW | MINERALYS THERAPEUTICS INC | MLYS | +1,591,917 | +$57.8M | $0 |
| NEW | EVOMMUNE INC | EVMN | +1,897,362 | +$32.5M | $0 |
| NEW | ABIVAX SA | AAVXF | +78,125 | +$10.5M | $0 |
| NEW | INVENTIVA SA | IVEVF | +1,818,181 | +$8.5M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 20255 pos · $176.6M
Top 5 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | KESTRA MED TECHNOLOGIES LTD | BEKE | 2,540,106 | $67.4M | 38.14% |
| 2 | MINERALYS THERAPEUTICS INC | MLYS | 1,591,917 | $57.8M | 32.71% |
| 3 | EVOMMUNE INC | EVMN | 1,897,362 | $32.5M | 18.39% |
| 4 | ABIVAX SA | AAVXF | 78,125 | $10.5M | 5.97% |
| 5 | INVENTIVA SA | IVEVF | 1,818,181 | $8.5M | 4.79% |